Viewing Study NCT04247633


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-02-27 @ 5:09 PM
Study NCT ID: NCT04247633
Status: UNKNOWN
Last Update Posted: 2020-04-20
First Post: 2020-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module